Skip to main content
In stock | Targeted Therapy (Investigational)

Guadecitabine

Oncology Type Hematologic (MDS/AML)
Drug Class / Mechanism Hypomethylating / Investigational Agent
No Image
Description

Guadecitabine is classified as a Hypomethylating / Investigational Agent, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Hematologic (MDS/AML)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3